Results 161 to 170 of about 8,581 (194)

Regarding "The molecular mechanisms through which psilocybin prevents suicide: evidence from network pharmacology and molecular docking analyses". [PDF]

Transl Psychiatry
Kristensen J.
europepmc   +1 more source

Predictors of the Effectiveness of Psychedelics in Treating Depression-A Scoping Review. [PDF]

Int J Mol Sci
Chmiel J, Rybakowski F.
europepmc   +1 more source

India's Unique Legal Framework for Psilocybin Mushroom Research: An Unprecedented Opportunity in Psychiatric Therapeutics. [PDF]

Indian J Psychol Med
Tom A, Reddy BSC, Sethi MIS, Math SB.
europepmc   +1 more source

Pilot study of psilocybin in patients with post-treatment lyme disease. [PDF]

Sci Rep
Garcia-Romeu A, Naudé GP, Rebman AW, So S, Yaffe A, Geithner I, Kozero EA, Yang T, Soloski MJ, Aucott JN.   +9 more
europepmc   +1 more source

Psychedelics and Autism Therapy: A Review of Current Research and Future Directions. [PDF]

Curr Issues Mol Biol
Gondi CS, Gnanamony M, Gondi TP, Nersesyan L, Demirkhanyan L.   +4 more
europepmc   +1 more source

Reshaping human neurons. [PDF]

Elife
Maltman JL, González-Maeso J.
europepmc   +1 more source

Electrophysiological effects of psilocybin co-administered with midazolam. [PDF]

Transl Psychiatry
Sutherland MH, Nicholas CR, Lennertz RC, Wenthur CJ, Krause BM, Sauder CJ, Riedner BA, Smith RF, Hutson PR, Raison CL, Banks MI.   +10 more
europepmc   +1 more source

Psychedelic Therapies for Comorbid Major Depressive Disorder and Chronic Pain: A Review of Putative Mechanisms of Action. [PDF]

Pharmacol Res Perspect
Kazdan J, Ladha KS, Husain MI.
europepmc   +1 more source

A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populations. [PDF]

Ther Adv Psychopharmacol
Deutsch A, Contreras LE, Kratina S, Mayo LM.   +3 more
europepmc   +1 more source